Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong
· Delayed Price · Currency is HKD 6.33
+0.05 (0.80%)
Apr 3, 2025, 4:08 PM HKT
HKG:0512 Revenue
In the year 2024, Grand Pharmaceutical Group had annual revenue of 11.64B HKD with 10.59% growth. Grand Pharmaceutical Group had revenue of 5.60B in the half year ending December 31, 2024, with 28.69% growth.
Revenue
11.64B
Revenue Growth
+10.59%
P/S Ratio
1.90
Revenue / Employee
971.46K
Employees
11,987
Market Cap
22.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.64B | 1.12B | 10.59% |
| Dec 31, 2023 | 10.53B | 967.31M | 10.12% |
| Dec 31, 2022 | 9.56B | 964.31M | 11.22% |
| Dec 31, 2021 | 8.60B | 2.25B | 35.34% |
| Dec 31, 2020 | 6.35B | -237.72M | -3.61% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| WuXi Biologics | 19.87B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Alibaba Health Information Technology | 31.39B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |